Neurocrine Bio. (NBIX) Pipeline Remains Under Appreciated - RBC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- S&P 500, Nasdaq set for higher open as SK Hynix lifts chips; Fed in focus
- SK Hynix shares surge after Q3 profit beats expectations
- Oil up 1% as Saudi Arabian refinery attack reignites supply concerns
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| Neurocrine Biosciences, Inc. (NASDAQ: NBIX) | Delayed: 144.70 -1.3 (0.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $146.00 | 52 Week High | $58.46 | |||
| Open | $144.56 | 52 Week Low | $31.25 | |||
| Day High | $145.47 | P/E | N/A | |||
| Day Low | $143.00 | EPS | $-0.69 | |||
| Volume | 20,676 | |||||
